Vedolizumab
Indication
Prevention of recurrence of ulcerative colitis following surgery.
Black
Brand:
Entyvio
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Gastro-intestinal system
Background
There is a lack of evidence for TNF-alpha inhibitors or other biologic agents to support their use in the prevention of recurrence following surgery for UC.
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: